• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单支血管及中度冠状动脉病变中动脉粥样硬化组织类型的危险因素:一项横断面研究。

Risk factors of atherosclerotic tissue types in single-vessel and intermediate coronary lesions: a cross-sectional study.

作者信息

Wang Xianjin, Chen Qun, Xu Yu, Wang Yanqing, Yang Yang, Gu Ming, Xu Haihua, Zhao Yanfang

机构信息

Department of Cardiology, the Eighty-first Hospital of PLA Affiliated with Anhui Medical University, No. 34, Biao 34, Yanggongjing, Qinhuai District, Nanjing, Jiangsu, 210000, China.

Department of Cardiology, the Eighty-first Hospital of PLA Affiliated with the Nanjing University of Chinese Medicine, Nanjing, China.

出版信息

Lipids Health Dis. 2017 Mar 23;16(1):63. doi: 10.1186/s12944-017-0456-z.

DOI:10.1186/s12944-017-0456-z
PMID:28335787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5364583/
Abstract

BACKGROUND

Few data exist that correlate lesion-related risk factors such as conventional cardiovascular risks or lipoprotein-associated phospholipase A2 (Lp-PLA2) with tissue types within atherosclerotic plaques in patients with single-vessel and intermediate coronary lesions.

METHODS

One hundred and ninety-two patients with single-vessel and intermediate coronary lesions were enrolled in a cross-sectional study and divided into two groups: stable angina pectoris (SAP) and acute coronary syndrome (ACS) groups. Data regarding clinical characteristics and Lp-PLA2 mass were collected. Using iMAP-IVUS, lumen areas were manually traced to determine the minimum lumen area (MLA) at 1-mm intervals in diseased segments. At the minimum lumen lesion, areas of different types of atherosclerotic tissue [i.e., areas of fibrous plaque tissue (FP), fibro-fatty tissue (FF), dense calcium (DC) and necrotic core (NC)], vascular external elastic membrane (EEMCSA) and plaque and media (P&MCSA) were calculated using the built-in iMap algorithm. Plaque burden was computed as P&MCSA divided by EEMCSA.

RESULTS

In a univariate analysis, glycosylated hemoglobin A1C (GHbA1C), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), hypertension, Lp-PLA2 and a history of taking statins predicted the degree of FP and NC area, as well as plaque burden, but were not significant predictors of FF or DC area. In a multivariate analysis, Lp-PLA2 and HbA1c remained independent predictors of plaque burden, FP and NC area. However, the results of the regression analyses were not identical when the SAP and ACS groups were analyzed separately. Lp-PLA2, diabetes and NC area were significant predictors of acute coronary lesions, and the predictive value of Lp-PLA2 was confirmed by the finding of a high area-under-the-curve in a ROC analysis (0.837, 95% CI:0.778-0.895, P = 0.000), as well as by the reasonable sensitivity and specificity of cut-off values.

CONCLUSIONS

GHbA1C and Lp-PLA2 were strong independent predictors of plaque burden and FP and NC area at the minimum lumen lesion in patients with single-vessel and intermediate coronary lesions. Furthermore, Lp-PLA2 has a certain predictive value for acute coronary lesions.

摘要

背景

在单支冠状动脉中度病变患者中,关于病变相关危险因素(如传统心血管危险因素或脂蛋白相关磷脂酶A2(Lp-PLA2))与动脉粥样硬化斑块内组织类型之间相关性的数据较少。

方法

192名单支冠状动脉中度病变患者纳入一项横断面研究,并分为两组:稳定型心绞痛(SAP)组和急性冠状动脉综合征(ACS)组。收集临床特征和Lp-PLA2质量的数据。使用iMAP-IVUS,手动描绘管腔面积以确定病变节段中每1毫米间隔处的最小管腔面积(MLA)。在最小管腔病变处,使用内置iMap算法计算不同类型动脉粥样硬化组织的面积[即纤维斑块组织(FP)、纤维脂肪组织(FF)、致密钙(DC)和坏死核心(NC)的面积]、血管外弹性膜(EEMCSA)以及斑块和中膜(P&MCSA)。斑块负荷计算为P&MCSA除以EEMCSA。

结果

在单因素分析中,糖化血红蛋白A1C(GHbA1C)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、高血压、Lp-PLA2以及服用他汀类药物的病史可预测FP和NC面积程度以及斑块负荷,但不是FF或DC面积的显著预测因素。在多因素分析中,Lp-PLA2和糖化血红蛋白仍为斑块负荷、FP和NC面积的独立预测因素。然而,当分别分析SAP组和ACS组时,回归分析结果并不相同。Lp-PLA2、糖尿病和NC面积是急性冠状动脉病变的显著预测因素,并且Lp-PLA2的预测价值通过ROC分析中较高的曲线下面积(0.837,95%CI:0.778 - 0.895,P = 0.000)以及截断值合理的敏感性和特异性得到证实。

结论

在单支冠状动脉中度病变患者中,GHbA1C和Lp-PLA2是最小管腔病变处斑块负荷以及FP和NC面积的强有力独立预测因素。此外,Lp-PLA2对急性冠状动脉病变具有一定的预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae4/5364583/78d61e12cb34/12944_2017_456_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae4/5364583/78d61e12cb34/12944_2017_456_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae4/5364583/78d61e12cb34/12944_2017_456_Fig1_HTML.jpg

相似文献

1
Risk factors of atherosclerotic tissue types in single-vessel and intermediate coronary lesions: a cross-sectional study.单支血管及中度冠状动脉病变中动脉粥样硬化组织类型的危险因素:一项横断面研究。
Lipids Health Dis. 2017 Mar 23;16(1):63. doi: 10.1186/s12944-017-0456-z.
2
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.脂蛋白相关磷脂酶 A2(Lp-PLA2)与急性冠状动脉综合征:与低密度脂蛋白胆固醇的关系。
Can J Cardiol. 2013 Dec;29(12):1679-86. doi: 10.1016/j.cjca.2013.09.026. Epub 2013 Oct 2.
3
[Plaque features in saphenous vein graft evaluated by virtual histology intravascular ultrasound].[应用虚拟组织学血管内超声评估大隐静脉移植血管的斑块特征]
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Jan 24;47(1):26-33. doi: 10.3760/cma.j.issn.0253-3758.2019.01.003.
4
Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.脂蛋白相关磷脂酶 A2 在心脏疾病中的作用:不稳定型冠状动脉疾病的潜在早期生物标志物。
Clin Lab. 2020 May 1;66(5). doi: 10.7754/Clin.Lab.2019.190719.
5
[Correlation between serum inflammatory cytokine levels and fibrous cap thickness of fibrofatty plaque in coronary culprit lesions].[血清炎症细胞因子水平与冠状动脉罪犯病变中纤维脂肪斑块纤维帽厚度的相关性]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jul 24;45(7):566-571. doi: 10.3760/cma.j.issn.0253-3758.2017.07.004.
6
[Changes of serum lipoprotein-related phospholipase A2 in patients with white matter lesion based on KIM classification and its correlation with carotid atherosclerotic plaque].基于KIM分类的白质病变患者血清脂蛋白相关磷脂酶A2的变化及其与颈动脉粥样硬化斑块的相关性
Zhonghua Yi Xue Za Zhi. 2020 Apr 21;100(15):1130-1135. doi: 10.3760/cma.j.cn112137-20191125-02558.
7
Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT.正性和负性病变部位重构对临床结局的影响:来自 PROSPECT 的见解。
JACC Cardiovasc Imaging. 2014 Jan;7(1):70-8. doi: 10.1016/j.jcmg.2013.10.007.
8
Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.脂蛋白相关磷脂酶A2与亚临床动脉粥样硬化风险相关,但在一般日本人群中未得到孟德尔随机化分析的支持。
Atherosclerosis. 2016 Mar;246:141-7. doi: 10.1016/j.atherosclerosis.2015.12.027. Epub 2015 Dec 23.
9
Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.血清脂蛋白相关磷脂酶A2、缺血修饰白蛋白与急性冠状动脉综合征之间的关联:一项横断面研究。
Heart Vessels. 2019 Oct;34(10):1608-1614. doi: 10.1007/s00380-019-01403-3. Epub 2019 Apr 8.
10
Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.血清Lp-PLA2水平升高与冠状动脉疾病严重程度独立相关:一项中国人群的横断面研究
BMC Cardiovasc Disord. 2015 Feb 26;15:14. doi: 10.1186/s12872-015-0001-9.

引用本文的文献

1
Change in lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndrome.急性冠状动脉综合征患者脂蛋白相关磷脂酶A2的变化及其与心血管结局的关联。
Medicine (Baltimore). 2018 Jul;97(28):e11517. doi: 10.1097/MD.0000000000011517.

本文引用的文献

1
Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.急性冠脉综合征后达拉帕利德对主要冠脉事件的影响:SOLID-TIMI 52 随机临床试验。
JAMA. 2014 Sep 10;312(10):1006-15. doi: 10.1001/jama.2014.11061.
2
Darapladib for preventing ischemic events in stable coronary heart disease.达肝素钠预防稳定性冠心病的缺血事件。
N Engl J Med. 2014 May 1;370(18):1702-11. doi: 10.1056/NEJMoa1315878. Epub 2014 Mar 30.
3
Construction and validation of a plaque discrimination score from the anatomical and histological differences in coronary atherosclerosis: the Liverpool IVUS-V-HEART (Intra Vascular UltraSound-Virtual-Histology Evaluation of Atherosclerosis Requiring Treatment) study.
从冠状动脉粥样硬化的解剖和组织学差异构建和验证斑块判别评分:利物浦 IVUS-V-HEART(需要治疗的动脉粥样硬化的血管内超声-虚拟组织学评估)研究。
EuroIntervention. 2014 Nov;10(7):815-23. doi: 10.4244/EIJV10I7A141.
4
In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study.射频血管内超声检测高危冠状动脉斑块及心血管转归:atheroremovius 研究结果。
Eur Heart J. 2014 Mar;35(10):639-47. doi: 10.1093/eurheartj/eht484. Epub 2013 Nov 19.
5
Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.载脂蛋白相关磷脂酶 A2 活性的变化可预测冠心病事件,并在一定程度上解释普伐他汀治疗效果:来自缺血性疾病长期普伐他汀干预研究的结果。
J Am Heart Assoc. 2013 Oct 23;2(5):e000360. doi: 10.1161/JAHA.113.000360.
6
Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.支持 Lp-PLA2 生成的溶血磷脂酰胆碱在人类动脉粥样硬化斑块炎症中起关键作用的证据。
Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1505-12. doi: 10.1161/ATVBAHA.112.249854. Epub 2012 Apr 12.
7
Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes.磷脂酶 A2 酶、大剂量阿托伐他汀与急性冠脉综合征后缺血事件预测。
Circulation. 2012 Feb 14;125(6):757-66. doi: 10.1161/CIRCULATIONAHA.111.063487. Epub 2012 Jan 9.
8
A prospective natural-history study of coronary atherosclerosis.前瞻性冠状动脉粥样硬化的自然病史研究。
N Engl J Med. 2011 Jan 20;364(3):226-35. doi: 10.1056/NEJMoa1002358.
9
Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.脂蛋白相关磷脂酶 A(2)与冠心病、卒中和死亡风险:32 项前瞻性研究的协作分析。
Lancet. 2010 May 1;375(9725):1536-44. doi: 10.1016/S0140-6736(10)60319-4.
10
Characterisation of atherosclerotic plaque by spectral similarity of radiofrequency intravascular ultrasound signals.通过射频血管内超声信号的频谱相似性对动脉粥样硬化斑块进行表征。
EuroIntervention. 2009 May;5(1):133-9. doi: 10.4244/eijv5i1a21.